Articleposted 2024-10-09 16:48:33
Wild-Type p53 Overexpression in NPM1-Mutated AML: Potential Implications for Disease Biology and Therapy Response
Paul Barone, Siarhei Dzedzik, Ashley Kleinman, Christopher Chin, Cem Meydan, Itzel Valencia, Mayumi Sugita, and 7 more authors
Under Review
at
Articleposted 2024-09-04 05:21:47
Human iPSCs-based modeling unveils chromatin remodeling induced by SETBP1 mutation as a potential initiating factor in GATA2 deficiency
Alessandra Giorgetti, Oskar Marin-Bejar, Joan Pera, Damià Romero-Moya, Eric Torralba, Maximiliano Distefano, Clara Berenguer Balaguer, and 9 more authors
Under Review
at
Brief Communicationposted 2024-08-27 19:44:46
LSD1 and GCN5 inhibition facilitates Am80 (tamibarotene)-mediated differentiation therapy in RARA-high non-APL AML
Tino Schenk, Faezeh Ghazvini Zadegan, Franziska Fiedler, Clara Stanko, Laura Ölsner, Jacqueline Schuett, Setenay Özcan, and 10 more authors
Posted
at
Articleposted 2024-06-25 20:37:00
MECOM promotes leukemia progression and inhibits mast cell differentiation through functional competition with GATA2
Susumu Goyama, Kohei Iida, Mayuko Nakanishi, Jakushin Nakahara, Shuhei Asada, Tomoya Isobe, Tomohiro Yabushita, and 4 more authors
Under Revision
at
Articleposted 2024-06-04 14:43:05
Rapid increase of C/EBPα p42 induces growth arrest of AML cells by Cop1 deletion in Trib1-expressing AML
Takuro Nakamura, Yoshitaka Sunami, Seiko Yoshino, Yukari Yamazaki, Takashi Iwamoto
Published
at
Articleposted 2024-05-14 08:44:24
Mesenchymal stem cell-derived S100A8 facilitates leukemia stem cell maintenance via TLR4/PI3K/Akt signaling
Fuling Zhou, Xiaoyan Liu, Jinxian Wu, Xinqi Li, Ruiyang Pan, Li Liu, Tingting Huang, and 13 more authors
Posted
at
Articleposted 2024-03-27 06:38:26
HDAC7 is a specific therapeutic target in Acute Erythroid Leukemia
Susumu Goyama, Wenyu Zhang, Keita Yamamoto, Yu-Hsuan Chang, Tomohiro Yabushita, Yangying Hao, Ruka Shimura, and 6 more authors
Published
at
Articleposted 2024-03-04 10:44:11
Post-transplant cyclophosphamide separates graft-versus host disease and graft versus leukemia effects after HLA- matched stem-cell transplantation for AML
Avichai Shimoni, Christophe Peczynski, Myriam Labopin, Alexander Kulagin, Ellen Meijer, Jan CORNELISSEN, Goda Choi, and 13 more authors
Under Review
at
Articleposted 2024-02-07 19:42:07
HDZ-740, a Potent FLT3 Inhibitor to Overcome FLT3 Mutations of Acute Myeloid Leukemia
Peiju Qiu, Ting Yang, Shijie Bi, Yan Gao, Liping Wang, Yanyan Chu, Rilei Yu, and 3 more authors
Posted
at
Articleupdated 2024-02-02 19:02:15
No impact of time from diagnosis to treatment on survival in newly diagnosed AML treated with venetoclax-based regimens
Thomas Weber, Andreas Burchert, Martin Kaufmann, Dirk Niemann, Markus Schaich, Wolfgang Blau, Alexander Kiani, and 32 more authors
Published
at
